SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-018695
Filing Date
2018-08-02
Accepted
2018-08-02 08:46:34
Documents
57
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q omed-10q_20180630.htm 10-Q 1532937
2 EX-10.1 omed-ex101_28.htm EX-10.1 31979
3 EX-31.1 omed-ex311_8.htm EX-31.1 16499
4 EX-31.2 omed-ex312_6.htm EX-31.2 16517
5 EX-32.1 omed-ex321_9.htm EX-32.1 8748
  Complete submission text file 0001564590-18-018695.txt   5828587

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT omed-20180630.xml EX-101.INS 1387991
7 XBRL TAXONOMY EXTENSION SCHEMA omed-20180630.xsd EX-101.SCH 36976
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE omed-20180630_cal.xml EX-101.CAL 29581
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omed-20180630_def.xml EX-101.DEF 155705
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE omed-20180630_lab.xml EX-101.LAB 258674
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omed-20180630_pre.xml EX-101.PRE 246988
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35993 | Film No.: 18986813
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1